4//SEC Filing
Farid Marjan 4
Accession 0001415889-23-009143
CIK 0001479419other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 8:00 PM ET
Size
7.6 KB
Accession
0001415889-23-009143
Insider Transaction Report
Form 4
Farid Marjan
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2023-05-31−1,600→ 0 totalExercise: $6.35Exp: 2032-10-30→ Common Stock (1,600 underlying) - Award
Common Stock
2023-05-31+1,600→ 1,600 total
Footnotes (3)
- [F1]On May 31, 2023, the issuer canceled, pursuant to the issuer's option exchange program, all outstanding unexercised options granted to the reporting person. In exchange for the unvested options, the reporting person received a grant of 1,600 RSUs that vest over three years, with 86% of such RSUs vesting on May 31, 2025 and 14% of such RSUs vesting on May 31, 2026, in each case, subject to the reporting person's continued service with the issuer. Each RSU represents a contingent right to receive one share of the issuer's common stock.
- [F2]Includes 1,600 unvested RSUs.
- [F3]The cancelled option was granted on October 31, 2022 and provided for vesting with respect to 1/3rd of the shares underlying the option on October 31, 2023 and as to an additional 1/36th of the shares underlying the option at the end of each successive one-month period thereafter until October 31, 2025.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001952098
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 8:00 PM ET
- Size
- 7.6 KB